Patents by Inventor Susan Francis

Susan Francis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELECTRICAL CONTACT ARRANGEMENT FOR MICROFABRICATED ULTRASONIC TRANSDUCER
    Publication number: 20240122073
    Abstract: An ultrasound-on-a-chip device has an ultrasonic transducer substrate with plurality of transducer cells, and an electrical substrate. For each transducer cell, one or more conductive bond connections are disposed between the ultrasonic transducer substrate and the electrical substrate. Examples of electrical substrates include CMOS chips, integrated circuits including analog circuits, interposers and printed circuit boards.
    Type: Application
    Filed: June 6, 2023
    Publication date: April 11, 2024
    Applicant: BFLY Operations, Inc
    Inventors: Jonathan M. Rothberg, Susan A. Alie, Jaime Scott Zahorian, Paul Francis Cristman, Keith G. Fife
  • Malaria vaccines
    Patent number: 8012493
    Abstract: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.
    Type: Grant
    Filed: December 8, 2009
    Date of Patent: September 6, 2011
    Assignees: Seattle Biomedical Research Institute, The United States of America as represented by the Secretary of the Army
    Inventors: Michal Fried, Patrick E Duffy, Susan Francis, Jason P Wendler, Theonest K Mutabingwa, Andrew Oleinikov
  • Malaria Vaccines
    Publication number: 20100172929
    Abstract: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.
    Type: Application
    Filed: December 8, 2009
    Publication date: July 8, 2010
    Applicants: SEATTLE BIOMEDICAL RESEARCH INSTITUTE, UNITED STATES ARMY
    Inventors: Michal Fried, Patrick E. Duffy, Susan Francis, Jason P. Wendler, Theonest K. Mutabingwa, Andrew Oleinikov
  • Malaria vaccines
    Patent number: 7655247
    Abstract: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.
    Type: Grant
    Filed: January 3, 2008
    Date of Patent: February 2, 2010
    Assignees: Seattle Biomedical Research Institute, The United States of America as represented by the Army
    Inventors: Michal Fried, Patrick E. Duffy, Susan Francis, Jason P. Wendler, Theonest K. Mutabingwa, Andrew Oleinikov
  • Malaria vaccines
    Publication number: 20080213291
    Abstract: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.
    Type: Application
    Filed: January 3, 2008
    Publication date: September 4, 2008
    Inventors: Michal Fried, Patrick E. Duffy, Susan Francis, Jason P. Wendler, Theonest K. Mutabingwa, Andrew Oleinikov
  • Malaria vaccines
    Publication number: 20070036819
    Abstract: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.
    Type: Application
    Filed: August 8, 2006
    Publication date: February 15, 2007
    Inventors: Michal Fried, Patrick Duffy, Susan Francis, Jason Wendler, Theonest Mutabingwa